MedTrace Logo

Collection of Blood Samples for New Diagnostic Devices 2

NCT05568966 · Status: RECRUITING · Phase: NA · Type: INTERVENTIONAL · Enrollment: 20000

Last updated 2026-04-22

No results posted yet for this study

Summary

To research and develop new state of the art diagnostic biomarkers on the LumiraDx Platform that are comparable to the approved gold standard reference methods and will radically enhance clinicians and patients ability to monitor health conditions and improve outcomes by delivering the results near patient at the point of care.

Conditions

Interventions

DIAGNOSTIC_TEST

Venous blood draw

Venepuncture to draw up to 24mL of venous blood.

DIAGNOSTIC_TEST

Fingerstick

Capillary blood draw

Sponsors & Collaborators

  • LumiraDx UK Limited

    lead INDUSTRY

Principal Investigators

  • Roy Gardner · NHS National Waiting Times Centre Board

  • Alasdair Gray · NHS Lothian

  • Allan Cameron · NHS Greater Glasgow & Clyde

  • David Lowe · NHS Greater Glasgow & Clyde

  • Santosh Bongale · NHS Greater Glasgow & Clyde

  • Fiona Hunter · NHS Lanarkshire

Study Design

Allocation
NA
Purpose
OTHER
Masking
NONE
Model
SINGLE_GROUP

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2022-07-11
Primary Completion
2026-08-20
Completion
2026-08-20

Countries

  • United Kingdom

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05568966 on ClinicalTrials.gov